Pinter, Andreas http://orcid.org/0000-0002-1330-1502
Soliman, Ahmed M. http://orcid.org/0009-0008-8632-1396
Pivneva, Irina http://orcid.org/0000-0003-1101-5200
Ghanbariamin, Roksana
Yang, Min
Truong, Bang http://orcid.org/0000-0002-8654-5444
Puig, Luis http://orcid.org/0000-0001-6083-0952
Lebwohl, Mark
Funding for this research was provided by:
AbbVie
Article History
Received: 19 March 2024
Accepted: 9 April 2024
First Online: 10 May 2024
Declarations
:
: Andreas Pinter has served as an advisor and/or speaker and/or received grants and/or served as an investigator for AbbVie, Almirall Hermal, Amgen, Biogen, BMS, Boehringer Ingelheim, Celgene, GlaxoSmithKline, Eli Lilly, Eva Pharma, Galderma, Hexal, Janssen, LEO Pharma, MC2, Medac, Merck Serono, Mitsubishi, MSD, Novartis, Pascoe, Pfizer, Tigercat Pharma, Regeneron, Roche, Sandoz Biopharmaceuticals, Sanofi Genzyme, Schering-Plough, UCB, and Zuellig Pharma. Luis Puig has received consultancy/speaker’s honoraria from and/or participated in clinical trials sponsored by AbbVie, Almirall, Amgen, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, LEO Pharma, Lilly, Novartis, Pfizer, Sandoz, Sanofi, and UCB. Mark Lebwohl is an employee of Mount Sinai and receives research funds from: AbbVie, Amgen, Arcutis, Avotres, Boehringer Ingelheim, Cara Therapeutics, Dermavant Sciences, Eli Lilly, Incyte, Janssen Research & Development, LLC, Ortho Dermatologics, Regeneron, and UCB, Inc., and is a consultant for Aditum Bio, Almirall, AltruBio Inc., AnaptysBio, Arcutis, Inc., Aristea Therapeutics, Avotres Therapeutics, Brickell Biotech, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Castle Biosciences, Celltrion, CorEvitas, Dermavant Sciences, Dr. Reddy, EPI, Evommune, Inc., Facilitatation of International Dermatology Education, Forte Biosciences, Foundation for Research and Education in Dermatology, Galderma, Helsinn, Incyte, LEO Pharma, Meiji Seika Pharma, Mindera, Pfizer, Seanergy, Strata, Trevi, and Verrica. Irina Pivneva, Roksana Ghanbariamin, and Min Yang are employees of Analysis Group, Inc., which has received consultancy fees from AbbVie. Ahmed M. Soliman and Bang Truong are full-time employees of AbbVie and may hold AbbVie stocks, stock options, or patents.
: This study was conducted in accordance with ethical principles that have their origin in the current Declaration of Helsinki and was consistent with International Conference on Harmonization Good Clinical Practice, Good Epidemiology Practices, and applicable regulatory requirements. This study utilized de-identified data from electronic health records, so no ethics committee approval was required.